ReviewOTO open
Complications Associated With Polycaprolactone (PCL) Use in Septorhinoplasty: A Systematic Review and Meta-Analysis.
Review in OTO open. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To evaluate the complications associated with polycaprolactone (PCL) use in septorhinoplasty. Data Sources: OVID EMBASE, OVID MEDLINE, SCOPUS, and PubMed. Review Methods: Studies reporting complications related to PCL in septorhinoplasty were included. Primary outcomes encompassed complications including tip deformity/warping, stiffness, deviation, infection, protrusion/extrusion, skin complications, epistaxis, and revision/reoperation. Subgroup analyses were conducted based on the type of operation, approach, surgery, graft, and material used. Results: A total of 13 studies, including 1194 patients, were analyzed. The pooled mean proportion of complications was relatively low, ranging from 0% to 0.72% (deviation 0% [95% CI -0.00 to 0.01], skin complications 0% [95% CI -0.00 to 0.00], infection 0.01% [95% CI 0.00-0.01], protrusion/extrusion 0.01% [95% CI 0.00-0.01], tip decrease/warping 0.02% [95% CI -0.00 to 0.04], revision/reoperation 0.03% [95% CI 0.02-0.03], epistaxis 0.07% [95% CI -0.06 to 0.21], and stiffness 0.72% [95% CI 0.59-0.85]). Subgroup analyses showed no statistically significant differences in complication based on operation type or graft type for tip decrease/warping ( Conclusion: PCL appears to demonstrate acceptable short- to mid-term safety in septorhinoplasty. However, long-term and comparative data are needed to better define its role.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.